Stay updated with breaking news from Anthony Back. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NetworkNewsWire Editorial Coverage NEW YORK, March 2, 2022 /PRNewswire/ -- Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can't be overstated.
Can psilocybin help relieve the mental health burden of clinicians affected by the COVID-19 pandemic? That’s a question University of Washington researchers aim…
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress - read this article along with other careers information, tips and advice on BioSpace
Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program - read this article along with other careers information, tips and advice on BioSpace
Dr. Thomas Laughren served as the director for the division of psychiatry products for the U.S. Food and Drug Administration for 29 years.